Blood Res 2019; 54(1): 4-6
Organ-specific considerations for marginal zone lymphomas in Korea, based on Consortium for Improving Survival of Lymphoma (CISL) and Korean clinical studies
Sung Yong Oh, M.D., Ph.D.1, Cheolwon Suh, M.D., Ph.D.2
1Department of Internal Medicine, Dong-A University Hospital, Busan, 2Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Received: November 19, 2018; Revised: December 27, 2018; Accepted: December 28, 2018; Published online: March 31, 2019.
© The Korean Journal of Hematology. All rights reserved.

cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


This Article

Current Issue


Indexed/Covered by

Today : 15  /
Total : 135,620